CD8 binding agents
US11236166B2 · kind B2 · utility
6Cited by
4References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 6, 2017 |
| Grant date | Feb 1, 2022 |
| Priority date | — |
| Expiry date | Mar 3, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in part, to agents that bind CD8 and their use as therapeutic and diagnostic agents. The present invention further relates to pharmaceutical compositions comprising the CD8 binding agents and their use in the treatment of various diseases, including, for example, cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.